The Impairment Of The Growth Hormone/Insulin-Like Growth Factor 1 (Igf-1) Axis In Heart Failure: A Possible Target For Future Therapy
MONALDI ARCHIVES FOR CHEST DISEASE(2018)
摘要
Hormonal abnormalities are quite common in chronic heart failure (CHF). The most studied hormonal axis in CHF is the impairment of Growth Hormone (GH)/Insulin Growth Factor-1(IGF-1), which in turn is defined either by a blunted response to GH stimulation test or low serum IGF-t values. Several independent groups reported that the presence of an abnormal GH/IGF-1 status in CHF is associated with a more severe disease, impaired functional capacity and reduced Survival rates. After the first encouraging results, double -blind controlled trials showed a neutral effect of the GH administration in patients. However, further studies reported positive results, when a GH-therapy is implemented only in those patients presenting a GH deficiency (replacement therapy).
更多查看译文
关键词
Chronic heart failure, growth hormone, IGF-1, anabolic deficiency, biomarker, outcomes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要